Back

Is there a role for prasugrel monotherapy?

29 August 2026 (08:51 - 09:09)
Organised by: Logo
Congress Presentation Part of: Novel antithrombotic approaches in acute coronary syndromes Pharmacotherapy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Patricia Guimaraes

Einstein Hospital Israelita, Sao Paulo (Brazil)

4 More presentations in this session

Presentation thumbnail
Unfractionated heparin in the field
Doctor J. Chen (Wuhan, CN)
Slides Video
Presentation thumbnail
Zalunfiban: is it really time to CELEBRATE?
Professor A. van 't Hof (Maastricht, NL)
Slides Video
Presentation thumbnail
Any hope for factor XI inhibition?
Doctor J. Ferreiro (Tarragona, ES)
Slides Video
Presentation thumbnail
Novel antithrombotic approaches in acute coronary syndromes - discussion
Video

Access the full session

Session thumbnail
Novel antithrombotic approaches in acute coronary syndromes
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 08:51 CET
You may be interested in
thumbnail
Congress Session
Oral antiplatelet therapy after acute coronary syndromes: how to choose the best regimen and the optimum duration
26 August 2023
thumbnail
Congress Presentation
Ticagrelor versus Prasugrel in Patients Undergoing Invasive Management of Coronary Artery Disease
31 August 2026
thumbnail
Congress Presentation
Ask the Trialists - PREMIUM
29 August 2026
thumbnail
Congress Presentation
P2Y12 inhibitor monotherapy in patients undergoing PCI.
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources